Literature DB >> 28096435

Regulation of aldosterone secretion by mineralocorticoid receptor-mediated signaling.

Cherish Chong1, Anis Hamid1, Tham Yao1, Amanda E Garza1, Luminita H Pojoga1, Gail K Adler1, Jose R Romero1, Gordon H Williams2.   

Abstract

We posit the existence of a paracrine/autocrine negative feedback loop, mediated by the mineralocorticoid receptor (MR), regulating aldosterone secretion. To assess this hypothesis, we asked whether altering MR activity in zona glomerulosa (ZG) cells affects aldosterone production. To this end, we studied ex vivo ZG cells isolated from male Wistar rats fed chow containing either high (1.6% Na+ (HS)) or low (0.03% Na+ (LS)) amount of sodium. Western blot analyses demonstrated that MR was present in both the ZG and zona fasciculata/zona reticularis (ZF/ZR/ZR). In ZG cells isolated from rats on LS chow, MR activation by fludrocortisone produced a 20% and 60% reduction in aldosterone secretion basally and in response to angiotensin II (ANGII) stimulation, respectively. Corticosterone secretion was increased in these cells suggesting that aldosterone synthase activity was being reduced by fludrocortisone. In contrast, canrenoic acid, an MR antagonist, enhanced aldosterone production by up to 30% both basally and in response to ANGII. Similar responses were observed in ZG cells from rats fed HS. Modulating glucocorticoid receptor (GR) activity did not alter aldosterone production by ZG cells; however, altering GR activity did modify corticosterone production from ZF/ZR/ZR cells both basally and in response to adrenocorticotropic hormone (ACTH). Additionally, activating the MR in ZF/ZR/ZR cells strikingly reduced corticosterone secretion. In summary, these data support the hypothesis that negative ultra-short feedback loops regulate adrenal steroidogenesis. In the ZG, aldosterone secretion is regulated by the MR, but not the GR, an effect that appears to be secondary to a change in aldosterone synthase activity.
© 2017 Society for Endocrinology.

Entities:  

Keywords:  adrenal cortex; aldosterone; corticosterone; zona fasciculata; zona glomerulosa

Mesh:

Substances:

Year:  2017        PMID: 28096435      PMCID: PMC5464000          DOI: 10.1530/JOE-16-0452

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  35 in total

1.  Inhibitory effect of hydrocortisone and analogues on adrenocortical secretion in dogs.

Authors:  W C BLACK; R S CRAMPTON; A S VERDESCA; R I NEDELJKOVIC; J G HILTON
Journal:  Am J Physiol       Date:  1961-12

2.  Inactivation of ACTH by isolated rat adrenals and inhibition of corticoid formation by adrenocortical hormones.

Authors:  M K BIRMINGHAM; E KURLENTS
Journal:  Endocrinology       Date:  1958-01       Impact factor: 4.736

3.  The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary-adrenal activity in humans with psychotic major depression.

Authors:  Anna Lembke; Rowena Gomez; Lakshika Tenakoon; Jennifer Keller; Gregory Cohen; Gordon H Williams; Fredric B Kraemer; Alan F Schatzberg
Journal:  Psychoneuroendocrinology       Date:  2012-06-21       Impact factor: 4.905

4.  Mineralocorticoid receptor blockade by canrenoate increases both spontaneous and stimulated adrenal function in humans.

Authors:  E Arvat; B Maccagno; R Giordano; M Pellegrino; F Broglio; L Gianotti; M Maccario; F Camanni; E Ghigo
Journal:  J Clin Endocrinol Metab       Date:  2001-07       Impact factor: 5.958

5.  Localization and regulation of glucocorticoid and mineralocorticoid receptor messenger RNAs in the hippocampal formation of the rat.

Authors:  J P Herman; P D Patel; H Akil; S J Watson
Journal:  Mol Endocrinol       Date:  1989-11

6.  Direct inhibitory effect of dexamethasone on steroidogenesis of human adrenal in vivo.

Authors:  E Saito; Y Ichikawa; M Homma
Journal:  J Clin Endocrinol Metab       Date:  1979-05       Impact factor: 5.958

7.  Inhibition of adrenal protein synthesis by steroids in vitro.

Authors:  L B Morrow; G N Burrow; P J Mulrow
Journal:  Endocrinology       Date:  1967-05       Impact factor: 4.736

8.  Aldosterone increases T-type calcium currents in human adrenocarcinoma (H295R) cells by inducing channel expression.

Authors:  O Lesouhaitier; A Chiappe; M F Rossier
Journal:  Endocrinology       Date:  2001-10       Impact factor: 4.736

9.  Androstenedione-mediated inhibition of 11 beta-hydroxylation in monolayer cell cultures of fetal calf adrenals.

Authors:  A Baird; K W Kan; S Solomon
Journal:  J Steroid Biochem       Date:  1983-05       Impact factor: 4.292

Review 10.  The new biology of aldosterone.

Authors:  John M C Connell; Eleanor Davies
Journal:  J Endocrinol       Date:  2005-07       Impact factor: 4.286

View more
  11 in total

1.  Histone demethylase LSD1 deficiency and biological sex: impact on blood pressure and aldosterone production.

Authors:  Yuefei Huang; Pei Yee Ting; Tham M Yao; Tsuyoshi Homma; Danielle Brooks; Isis Katayama Rangel; Gail K Adler; Jose R Romero; Jonathan S Williams; Luminita H Pojoga; Gordon H Williams
Journal:  J Endocrinol       Date:  2019-02-01       Impact factor: 4.286

2.  Lysine-Specific Demethylase-1 Deficiency Increases Agonist Signaling Via the Mineralocorticoid Receptor.

Authors:  Thitinan Treesaranuwattana; Kelly Yin Han Wong; Danielle L Brooks; Chee Sin Tay; Gordon H Williams; Jonathan S Williams; Luminita H Pojoga
Journal:  Hypertension       Date:  2020-03-11       Impact factor: 10.190

3.  Biological Sex Modulates the Adrenal and Blood Pressure Responses to Angiotensin II.

Authors:  Mohammad Zaki Shukri; Jia Wei Tan; Worapaka Manosroi; Luminita H Pojoga; Alicia Rivera; Jonathan S Williams; Ellen W Seely; Gail K Adler; Iris Z Jaffe; Richard H Karas; Gordon H Williams; Jose R Romero
Journal:  Hypertension       Date:  2018-04-23       Impact factor: 10.190

4.  Mineralocorticoid Receptor Antagonists Decrease the Rates of Positive Screening for Primary Aldosteronism.

Authors:  Yuta Tezuka; Adina F Turcu
Journal:  Endocr Pract       Date:  2020-12       Impact factor: 3.443

Review 5.  CIRMI-a new term for a concept worthy of further exploration: a narrative review.

Authors:  Gladness Dakalo Nethathe; Jeffrey Lipman; Ronald Anderson; Charles Feldman
Journal:  Ann Transl Med       Date:  2022-06

6.  Steroidogenic acute regulatory protein/aldosterone synthase mediates angiotensin II-induced cardiac fibrosis and hypertrophy.

Authors:  Wei-Wei Zhang; Rong-Hua Zheng; Feng Bai; Katelyn Sturdivant; Ning-Ping Wang; Erskine A James; Himangshu S Bose; Zhi-Qing Zhao
Journal:  Mol Biol Rep       Date:  2019-12-09       Impact factor: 2.316

7.  Dynamic responses of the adrenal steroidogenic regulatory network.

Authors:  Francesca Spiga; Eder Zavala; Jamie J Walker; Zidong Zhao; John R Terry; Stafford L Lightman
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-17       Impact factor: 11.205

Review 8.  Aldosterone and Mineralocorticoid Receptor System in Cardiovascular Physiology and Pathophysiology.

Authors:  Alessandro Cannavo; Leonardo Bencivenga; Daniela Liccardo; Andrea Elia; Federica Marzano; Giuseppina Gambino; Maria Loreta D'Amico; Claudia Perna; Nicola Ferrara; Giuseppe Rengo; Nazareno Paolocci
Journal:  Oxid Med Cell Longev       Date:  2018-09-19       Impact factor: 6.543

9.  Sex-specific differences in endoplasmic reticulum aminopeptidase 1 modulation influence blood pressure and renin-angiotensin system responses.

Authors:  Sanjay Ranjit; Jian Yao Wong; Jia W Tan; Chee Sin Tay; Jessica M Lee; Kelly Yin Han Wong; Luminita H Pojoga; Danielle L Brooks; Amanda E Garza; Stephen A Maris; Isis Akemi Katayama; Jonathan S Williams; Alicia Rivera; Gail K Adler; Gordon H Williams; Jose R Romero
Journal:  JCI Insight       Date:  2019-11-01

10.  Combined Salt and Caloric Restrictions: Potential Adverse Outcomes.

Authors:  Tsuyoshi Homma; Mika Homma; Yuefei Huang; Korapat Mayurasakorn; Nurul Mahamad Rodi; Anis Amalina Abdul Hamid; Shelley Hurwitz; Tham Yao; Gail K Adler; Luminita H Pojoga; Gordon H Williams; Jose R Romero
Journal:  J Am Heart Assoc       Date:  2017-10-11       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.